BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16570573)

  • 1. Allele-specific all-or-none PCR product diagnostic strategy for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies.
    Lin KP; Chou CH; Lee HY; Soong BW
    J Chin Med Assoc; 2006 Feb; 69(2):68-73. PubMed ID: 16570573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth Type 1A and hereditary neuropathy with liability to pressure palsies.
    Choi JR; Lee WH; Sunwoo IN; Lee EK; Lee CH; Lim JB
    Yonsei Med J; 2005 Jun; 46(3):347-52. PubMed ID: 15988805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies.
    Stronach EA; Clark C; Bell C; Löfgren A; McKay NG; Timmerman V; Van Broeckhoven C; Haites NE
    J Peripher Nerv Syst; 1999; 4(2):117-22. PubMed ID: 10442687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. French CMT Collaborative Research Group.
    Lopes J; LeGuern E; Gouider R; Tardieu S; Abbas N; Birouk N; Gugenheim M; Bouche P; Agid Y; Brice A
    Am J Hum Genet; 1996 Jun; 58(6):1223-30. PubMed ID: 8651299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs.
    Seeman P; Mazanec R; Zidar J; Hrusáková S; Ctvrtecková M; Rautenstrauss B
    Int J Mol Med; 2000 Oct; 6(4):421-6. PubMed ID: 10998431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A.
    Young P; Stögbauer F; Wiebusch H; Löfgren A; Timmerman V; Van Broeckhoven C; Ringelstein EB; Assmann G; Funke H
    Neurology; 1998 Mar; 50(3):760-3. PubMed ID: 9521270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies: detection of the recombination in Slovene patients and exclusion of the potentially recessive Thr118Met PMP22 point mutation.
    Leonardis L; Zidar J; Ekici A; Peterlin B; Rautenstrauss B
    Int J Mol Med; 1998 Feb; 1(2):495-501. PubMed ID: 9852256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies.
    Lorenzetti D; Pareyson D; Sghirlanzoni A; Roa BB; Abbas NE; Pandolfo M; Di Donato S; Lupski JR
    Am J Hum Genet; 1995 Jan; 56(1):91-8. PubMed ID: 7825607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP.
    Kiyosawa H; Lensch MW; Chance PF
    Hum Mol Genet; 1995 Dec; 4(12):2327-34. PubMed ID: 8634706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP).
    Timmerman V; Löfgren A; Le Guern E; Liang P; De Jonghe P; Martin JJ; Verhalle D; Robberecht W; Gouider R; Brice A; Van Broeckhoven C
    Hum Genet; 1996 Jan; 97(1):26-34. PubMed ID: 8557256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two PCR-based molecular methods in the diagnosis of CMT 1A and HNPP diseases in Chinese.
    Chen SR; Lin KP; Kuo HC; Chen CM; Hsieh ST; Lee MJ; Yang CC; Liu CS; Huang CC; Lyu RK; Ro LS
    Clin Neurol Neurosurg; 2008 May; 110(5):466-71. PubMed ID: 18353535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of PMP22 duplication and deletion using a panel of six dinucleotide tandem repeats.
    Gagic M; Markovic MK; Kecmanovic M; Keckarevic D; Mladenovic J; Dackovic J; Milic-Rasic V; Romac S
    Clin Chem Lab Med; 2016 May; 54(5):773-80. PubMed ID: 26479344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid and definitive test for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies using multiplexed real-time PCR.
    Lorentzos P; Kaiser T; Kennerson ML; Nicholson GA
    Genet Test; 2003; 7(2):135-8. PubMed ID: 12885335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of Charcot-Marie-Tooth 1A disease and hereditary neuropathy with liability to pressure palsies by quantifying CMT1A-REP sequences: consequences of recombinations at variant sites on chromosomes 17p11.2-12.
    Vandenberghe A; Latour P; Chauplannaz G; Chapon F; Pouget J; Dumas R; Laguenay A; Ollagnon E; Bost M; Duthel S; Chazot G; Boucherat M
    Clin Chem; 1996 Jul; 42(7):1021-5. PubMed ID: 8674184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of duplication/deletion of the PMP22 gene in patients with Charcot-Marie-Tooth disease Type 1A and hereditary neuropathy with liability to pressure palsy by real-time quantitative PCR using SYBR Green I dye.
    Kim SW; Lee KS; Jin HS; Lee TM; Koo SK; Lee YJ; Jung SC
    J Korean Med Sci; 2003 Oct; 18(5):727-32. PubMed ID: 14555828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electrophysiologic features of HNPP patients with 17p11.2 deletion.
    Hong YH; Kim M; Kim HJ; Sung JJ; Kim SH; Lee KW
    Acta Neurol Scand; 2003 Nov; 108(5):352-8. PubMed ID: 14616306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid quantitative PCR diagnostic strategy for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies.
    Chen SS
    J Chin Med Assoc; 2006 Feb; 69(2):58-9. PubMed ID: 16570571
    [No Abstract]   [Full Text] [Related]  

  • 18. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17.
    Chance PF; Abbas N; Lensch MW; Pentao L; Roa BB; Patel PI; Lupski JR
    Hum Mol Genet; 1994 Feb; 3(2):223-8. PubMed ID: 8004087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.
    Inoue K; Dewar K; Katsanis N; Reiter LT; Lander ES; Devon KL; Wyman DW; Lupski JR; Birren B
    Genome Res; 2001 Jun; 11(6):1018-33. PubMed ID: 11381029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of the 17p11.2--p12 region in a large cohort of patients with Charcot-Marie-Tooth (CMT) disease or hereditary neuropathy with liability to pressure palsies (HNPP).
    Kabzinska D; Pierscinska J; Kochanski A
    J Appl Genet; 2009; 50(3):283-8. PubMed ID: 19638685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.